Bleeding Disorders
From the Journals
Health costs over 25 times higher for hemophilia B patients than controls
From the Journals
High variability found in studies assessing hemophilia-related pain
From the Journals
Real-world outcomes of caplacizumab for iTTP comparable to clinical trial results
Conference Coverage
Close joint health monitoring essential with new hemophilia therapies
Conference Coverage
Joint pain in patients with hemophilia may be neuropathic
Conference Coverage
Type 3 von Willebrand a rare but serious bleeding disorder
Conference Coverage
Bleeding disorder diagnoses delayed by years in girls and women
Conference Coverage
Safety profiles of hemophilia agents vary widely
Conference Coverage
Factor VIII concentrate is here to stay in hemophilia A
From the Journals
Immunoabsorption shows promise as an adjunct treatment for high-risk acquired hemophilia
Feature
Doctors search for missing link between COVID-19 and ITP
“We don’t know much about platelet counts in COVID-19 at all.”